Schedule 13G Filing by Daniel Kaufman for DELCATH SYSTEMS, INC.
2026-03-20SEC Filing SCHEDULE 13G (0001099910-26-000129)
Daniel Kaufman has filed a Schedule 13G, reporting beneficial ownership of 1,766,432 shares of DELCATH SYSTEMS, INC. common stock, representing 5.08% of the class. This filing indicates Kaufman is an individual investor and acquired these shares without the purpose or effect of changing or influencing the control of the issuer. The filing was made on March 20, 2026, with the event date of the ownership change being March 18, 2026. Kaufman has sole voting and dispositive power over all the reported shares. The principal business office for Kaufman is located in San Juan, Puerto Rico.
Related industry:Medical Devices
Source:Original SEC Document β